Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG Dose Comparison in Haploidentical HSCT
NCT01883180Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jun 2013
- Primary completion
- Sep 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Nanfang Hospital, Southern Medical University. Started Jun 2013; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT01883180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01883180.